ea0029oc10.6 | Pituitary Clinical 2 | ICEECE2012
Felicetti F.
, Di Cuonzo D.
, Manicone R.
, Lazzarato F.
, Biasin E.
, Chiabotto P.
, Boccuzzi G.
, Brignardello E.
Introduction: The relation between GH treatment and cancer is still matter of debate. Childhood cancer survivors (CCS) have a high risk to develop second benign and malignant neoplasms (SNs), mainly as a consequence of radiation therapy. Thus, in patients with GH deficiency it is difficult to discriminate the oncological risk due to GH treatment from that caused by anticancer therapy and by individual susceptibility.Methods: We studied the prevalence of ...